Timothy Yeatman
Associate Director, Translational Research, Tampa General Hospital · FLORIDA HEALTH SCIENCES CENTER INC
Credentials: · · · · ·
History
- 1984–1991
Surgery
University
- 1980–1984
1976–1980
Research
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
JAMA · 1996 · 1,049 citations
Review · Nature reviews. Cancer · 2004 · Sole author · 962 citations
Nature Medicine · 2008 · 921 citations
- DC
47 papers
- AN
13 papers
12 papers
- RK
11 papers
- MM
10 papers
- RB
9 papers
- DR
8 papers
8 papers · 8 as a resident
Grants
- 2024–2029
National Cancer Institute · U01
Contact PI · $1.9M · University of South Florida
- 2019–2025
Clincial Validation of Apc and tp53 as Biomarkers for Cetuximab Response
National Cancer Institute · UH3
Contact PI · $916.9K · University of South Florida
- 2021–2024
National Cancer Institute · R21
Contact PI · $392.1K · University of South Florida
- 2021–2024
APC + TP53 Combinatorial Mutations Emerging as Biomarkers to Predict EGFRI Sensitivity
National Cancer Institute · R21
Contact PI · $385.1K · University of South Florida
Clinical trials
- 1999–2002
Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer
Principal investigator · Completed
H. Lee Moffitt Cancer Center and Research Institute